Harry W. Alcorn Jr., Chief Medical Officer at DiaMedica Therapeutics Inc. (DMAC), bought 7,260 shares at $2.67 ($19K) on 2019-08-16, disclosed to the SEC on 2019-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DMAC | BUY | 2019-03-29 | $669 | — | Filing → |
| DMAC | BUY | 2018-12-11 | $4K | — | Filing → |